Correlation Between Novacyt SA and Bone Biologics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Novacyt SA and Bone Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novacyt SA and Bone Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Novacyt SA and Bone Biologics Corp, you can compare the effects of market volatilities on Novacyt SA and Bone Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novacyt SA with a short position of Bone Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novacyt SA and Bone Biologics.

Diversification Opportunities for Novacyt SA and Bone Biologics

0.61
  Correlation Coefficient

Poor diversification

The 3 months correlation between Novacyt and Bone is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding Novacyt SA and Bone Biologics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bone Biologics Corp and Novacyt SA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novacyt SA are associated (or correlated) with Bone Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bone Biologics Corp has no effect on the direction of Novacyt SA i.e., Novacyt SA and Bone Biologics go up and down completely randomly.

Pair Corralation between Novacyt SA and Bone Biologics

Assuming the 90 days horizon Novacyt SA is expected to generate 2637.2 times less return on investment than Bone Biologics. But when comparing it to its historical volatility, Novacyt SA is 34.46 times less risky than Bone Biologics. It trades about 0.0 of its potential returns per unit of risk. Bone Biologics Corp is currently generating about 0.19 of returns per unit of risk over similar time horizon. If you would invest  2.50  in Bone Biologics Corp on October 13, 2024 and sell it today you would earn a total of  5,448  from holding Bone Biologics Corp or generate 217900.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Novacyt SA  vs.  Bone Biologics Corp

 Performance 
       Timeline  
Novacyt SA 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Novacyt SA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.
Bone Biologics Corp 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Bone Biologics Corp are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile technical and fundamental indicators, Bone Biologics showed solid returns over the last few months and may actually be approaching a breakup point.

Novacyt SA and Bone Biologics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Novacyt SA and Bone Biologics

The main advantage of trading using opposite Novacyt SA and Bone Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novacyt SA position performs unexpectedly, Bone Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bone Biologics will offset losses from the drop in Bone Biologics' long position.
The idea behind Novacyt SA and Bone Biologics Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Other Complementary Tools

Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk